Description
What is Tesamorelin 10mg?
Tesamorelin 10mg is a research peptide supplied as lyophilized powder in a vial labeled 10mg. It is intended for in-vitro laboratory research only. The product label identifies the labeled amount; the certificate of analysis records the tested sample’s analytical results separately.
See the purchase panel for the current price and availability.
Product documentation and research references
Match the batch number on your vial to its certificate of analysis. The Certificates of Analysis database provides batch documentation. Results for one tested sample do not establish the results of every vial or future batch.
For background reading, visit the Tesamorelin research overview. Published research does not establish the performance or suitability of this particular vial.
Reconstitution calculations and research-use limits
Use batch-specific documentation and your validated laboratory protocol for handling and reconstitution. This page does not specify a diluent, reconstitution volume, storage period or dose.
The peptide reconstitution calculator can check arithmetic from known mass, volume and target-amount inputs. It does not select an experimental amount or validate the material.
For in-vitro laboratory research only. Not for human or animal use, or for therapeutic or diagnostic use. Read the research-use disclaimer.
Current batch: CP-TES-2605-01
The current batch certificate from BT Labs identifies the testing material as Tesamorelin and the lot as CP-TES-2605-01. It lists May 11, 2026 as the test date and May 13, 2026 as the report date.
| Certificate field | Reported value |
|---|---|
| Labeled peptide content | 10mg |
| HPLC peptide purity | 99.7% |
| HPLC potency assay | 14.9mg |
| General appearance | White powder |
The product has a 10mg label amount. BT Labs reported 14.9mg of measured peptide content in the submitted batch sample. This batch-specific analytical result is reported separately from the product’s labeled amount. These results apply to this batch report and do not represent every Tesamorelin 10mg vial or future batch.
The certificate identifies excipients/fillers. Its HPLC peptide-purity result does not describe the proportion of Tesamorelin in the total powder mass. The report states that its testing does not provide information on particulate matter, microbial contamination or endotoxins.
View the displayed COA page for batch CP-TES-2605-01. The complete two-page report includes the supporting FTIR spectrum and HPLC chromatogram on page 2.

